TrialNCT01749137Phase 2Completed
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2013-09-28Actual
Enrollment · participants74Actual
Source updated2023-08-14Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.